Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ERYTECH Pharma S.A. Share Issue/Capital Change 2019

Mar 12, 2019

1295_dva_2019-03-12_bc729031-c462-42d7-bf24-d85f28fd3c3c.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2019

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France

Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com

Date Total of shares composing
the share capital
Total of brut(1) voting
rights
Total of net(2) voting
rights
December 31, 2018 17 940 035 19 525 606 19 523 106
January 31, 2019 17 940 035 19 525 918 19 523 418
February 28, 2019 17 940 035 19 525 792 19 523 292

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares.